Introduction
Following infection with bacteria, viruses, fungi and parasites, or after tissue injury, neutrophils are mobilized rapidly from blood and bone marrow niches to areas of damage or contagion via inflammatory agents such as N-formylated peptides, chemokines and danger signals. [1] [2] [3] With respect to infection, a variety of effector mechanisms, including release of reactive oxygen species (ROS), anti-microbial peptides and proteases are employed by the granulocytes to efficiently kill invading microbes. 1, 4 Neutrophils are thus considered essential beneficial cells, and their importance became evident when their removal from the inflammatory equation, such as in the case of neutropaenia or following the use of immunosuppressive agents, resulted in a substantial
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increase in the susceptibility to infection. 5, 6 However, exuberant infiltration and activation of neutrophils during sterile injury, autoimmunity or even during infection can lead to tissue damage. For example, matrix metalloproteinases (MMPs) secreted by neutrophils are thought to digest collagen, tendon and bone, which severely damages joints in rheumatoid arthritis (RA). 7 It is thus important to decipher how the physiological properties of neutrophils can be regulated in order to control over-zealous neutrophil responses.
In addition to direct effects during injury and infection, neutrophils can also modulate the responses of other immune cells, such as dendritic cells (DCs), and thus further influence inflammatory responses. Through direct cell-to-cell contact or indirectly through secreted factors, neutrophils can interact with DCs to alter their antigenpresenting abilities, cytokine production and/or polarization of T-cells. [8] [9] [10] For instance, DCs can engulf neutrophils and present the antigen(s) that was being processed by the neutrophils. In other situations, the granulocyte can directly transfer antigen(s) to DCs. [11] [12] [13] In addition, neutrophils are able to induce DCs to produce the pro-inflammatory cytokine interleukin (IL)-12p40, and potentiate the ability of these antigen-presenting cells (APCs) to differentiate T lymphocytes into a Th1 or Th17 phenotype. 10, 14 Because of these cell-to-cell interactions, over-exuberant neutrophil activation could augment and extend the pro-inflammatory properties of APCs such as DCs. Thus, the ability to control neutrophil function would indirectly regulate the actions of other potentially harmful immune cells.
The small heat-shock protein, alphaB-crystallin (aBC), has many protective functions, including chaperoning, antineurotoxic and immunosuppressive properties. 15 We, and colleagues, have shown that aBC treatment is beneficial in autoimmune diseases and after peripheral nerve injury due to its chaperoning, remyelinating and immune-dampening effects. [16] [17] [18] [19] [20] Most of these studies focused on the antiinflammatory effect of aBC on T-cells 17, 18 and macrophages 17, 21 because of the involvement of these cell types in the models used. It is suggested that exogenous aBC exerts its cellular effects by binding to and crossing the plasma membrane, 22 or signalling through the TLR2/CD14 receptor. 21 Whether aBC also impacts the biology of neutrophils remains unclear. van Noort et al. 21 have shown that microparticle-encapsulated aBC-treated macrophages reduced neutrophil activation and migration following lung injury. Additionally, Dieterich et al. 23 found that aBC regulated the release and expansion of Gr-1 + immunosuppressive immature immune cells from the bone marrow during tumour progression. Whether aBC directly influences neutrophil function to subsequently impact the activation of other immune cells has not, however, been elucidated. We therefore sought to establish whether the small heat-shock protein affects how neutrophils respond to inflammatory stimulation by assessing for cytokine secretion, activation state and effector mechanisms, such as ROS and MMP secretion. We also examined whether aBC-treated neutrophils could influence the response of other immune cells, specifically DCs. Altogether, we found that the crystallin mediated a small increase in IL-10 and MMP8 production by neutrophils, and that aBC-treated neutrophils reduced the production of IL-12p40 by DCs in both a contact-and non-contact-dependent manner.
Materials and methods

Mice
129S6 mice from Taconic (129SVETac, Germantown, NY) were housed and bred in a specific pathogen-free conventional unit at the University of Calgary where they had access to food and water ad libitum. Eight-12-week-old female mice were used for all experiments. All procedures were carried out in accordance with guidelines of the Canadian Council of Animal Care, and received approval by the University of Calgary Animal Resources and Ethics Committee.
Immune cell isolation from bone marrow
Hind limbs were removed from na€ ıve 129S6 mice, and bones carefully extracted from the surrounding tissue. Bone marrow was then flushed from the femurs and tibias using cold sterile phosphate-buffered saline (PBS). Cells were centrifuged at 295 9 g (Beckman Coulter Allegra X-12R) at 4°for 10 min.
Neutrophil isolation and stimulation
Neutrophils were isolated from the bone marrow of na€ ıve 129S6 animals using a neutrophil isolation kit (MACS Miltenyi, 130-097-658, Auburn, CA, USA). Briefly, cells were incubated with biotin-labelled non-neutrophil antibodies for 10 min at 4°, washed, incubated with anti-biotin magnetic beads for 15 min at 4°and then passed through magnetized ferromagnetic matrix columns. Eluted cells were collected and plated at 1 million cells/ml of media containing RPMI 1640, 5% heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin/streptomycin and 2 mM L-glutamine. For neutrophil-only experiments, cells were stimulated with 50 ng/ml recombinant mouse (rm)-granulocyte macrophage-colony-stimulating factor (GM-CSF; Invitrogen, PMC2015, Waltham, MA, USA) plus 1 lg/ml lipopolysaccharide (LPS; Sigma, L2654, St. Louis, MO, USA), and then treated with 2 lg/ml aBC [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] peptide (Stanford Pan Facility) for 20 hr at 37°and 5% CO 2 . We, and colleagues, have previously shown that the aBC [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] peptide as well as full-length aBC 17 reduces central nervous system inflammation 24 and activation of CD4 + T-cells. 
DC isolation and co-culture
Dendritic cells were derived from neutrophil-depleted bone marrow. After neutrophils were eluted from the bone marrow cell suspension using the neutrophil isolation kit, columns were removed from the magnet and the remaining cells flushed from the columns. The neutrophil-depleted cells were grown in RPMI 1640 media containing 10% heat-inactivated FBS, 100 U/ml penicillin/streptomycin, 2 mM L-glutamine and 20 ng/ml rm-GM-CSF for 4 days at 37°and 5% CO 2 . Wells were replenished with fresh rm-GM-CSF-containing media and grown for an additional 3 days. DCs were harvested using 0Á25% trypsin and gentle scraping, and plated at 20 000, 40 000 and 100 000 cells/ well in 96-well plates, 50 000 cells/well in 24-well plates, or 100 000 cells/well in 96-well transwell plates (Corning, 3391, Corning, NY, USA). Cells were starved from rm-GM-CSF for 48 hr. Pre-stimulated and aBC-treated neutrophils were added on top of the DCs at 100 000 DCs/well in 96-well plates or 250 000 DCs/well in 24-well plates. For the transwell system, 200 000 neutrophils/well were added on top of the 0Á4-lm pore polycarbonate membrane. For these co-cultures, neutrophils were prior stimulated with 5 ng/ml rm-GM-CSF plus 100 ng/ml LPS, and treated with 200 ng/ml aBC 73-92 peptide at 37°and 5% CO 2 for 20 hr. (ii) Delta À average Delta of GM-CSF-stimulated samples = Delta-Delta; (iii) 2 À(Delta-Delta) = fold change.
Flow cytometry
Cells were suspended in PBS containing 3% heat-inactivated FBS and their Fc receptors blocked for 5 min at room temperature using unlabelled anti-CD16/CD32 antibodies (BD Biosciences 553142). Cells were then stained for 30 min at 4°with the following BD Biosciences fluorescently-conjugated antibodies: FITC-conjugated CD45 (553080), PerCPconjugated CD45 (557235), APC-conjugated CD45 (559864), APC-Cy7-conjugated CD45 (557659), FITC-conjugated Ly6G (551460), PerCP-conjugated Ly6G (560602), FITC-conjugated CD11b (553310), PE-conjugated CD11c (557401), APC-conjugated CD11c (550261), PE-conjugated CD40 (561846), PerCP-conjugated CD80 (560526), PE-conjugated CD86 (560582) and FITC-conjugated I-A/I-E (MHC class II, 562009). An Attune acoustic focusing cytometer (Applied Biosystems, Waltham, MA, USA) was used with its blue and red lasers configured to measure the size, granularity and fluorescence intensity of cells bound with antibodies.
DC : neutrophil interaction assay
Neutrophils were stimulated with 5 ng/ml rm-GM-CSF plus 100 ng/ml LPS, and treated with 200 ng/ml aBC 73-92 peptide for 20 hr, washed and co-cultured with DCs for 24 hr. Cells were then fixed and images captured on an inverted microscope using phase contrast. METAMORPH Advanced software version 7Á7Á8Á0 was used to capture images in five locations in each well. Under phase contrast, neutrophils and DCs were distinguished by size and appearance ( 
Kinase inhibition assay
The following kinase inhibitors were purchased from Millipore (Burlington, MA, USA): LY294002 (Cat# 440202), a phosphoinositol-3-kinase (PI3K) inhibitor that blocks the phosphorylation of Akt; SB203580 (Cat# 559389), a p38 mitogen-activated protein kinase (MAPK) inhibitor that prevents the activation of MAPKAPK-2 by p38 MAPK; U0126 (Cat# 662005) that inhibits the kinase activity of MEK1/2 and downstream activation of MAPK p42/44; and cJun N-terminal kinase (JNK) inhibitor II (Cat# 420119), a small molecule inhibitor that blocks the kinase activity of JNK by competitive inhibition with respect to adenosine triphosphate. LY294002, SB203580, U0126 or JNK II (1 lM) was administered to neutrophils simultaneously with 50 ng/ml rm-GM-CSF + 1 lg/ml LPS stimulation and 2 lg/ml aBC [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] peptide, and incubated for 20 hr at 37°and 5% CO 2 . Supernatants were collected, and the amount of IL-10 secretion assessed by ELISA.
Viability assay
Neutrophils were stimulated with 50 ng/ml rm-GM-CSF + 1 lg/ml LPS, and treated with 2 lg/ml aBC 73-92 peptide in the presence or absence of 1 lM LY294002, SB203580, U0126 or JNK inhibitor II inhibitors for 20 hr. The Fc receptors on cells were blocked for 5 min at room temperature with unlabelled anti-CD16/CD32 antibodies. Cells were subsequently stored in 300 ll of PBS containing 3% heat-inactivated FBS on ice, resuspended, and 5 ll of propidium iodide added to the tube 30 seconds before processing by flow cytometry. Alternatively, neutrophils were stimulated with 5 ng/ml rm-GM-CSF + 100 ng/ml LPS, and treated with 200 ng/ml aBC 73-92 peptide for 20 hr and incubated with 5 ll of propidium iodide and 5 ll of Annexin V in binding buffer for 10 min before processing by flow cytometry. Cells that stained positive for propidium iodide and/or annexinV were considered non-viable.
Statistics
Results are expressed as the mean of each experiment in individual scatter plot data sets. Comparisons between groups were made by repeated-measures two-way ANOVA with S ıd ak post hoc tests, or repeated-measures one-way ANOVA with Dunnett's multiple comparison test. All statistical measures were completed using GRAPHPAD PRISM 6 software (GraphPad, La Jolla, CA). A value of P < 0Á05 was considered statistically significant.
Results
aBC induced a small increase in the secretion of IL-10 but did not alter the production of other cytokines in neutrophils
Neutrophils secrete a plethora of cytokines including TNF-a, IL-12p40, IL-6, IL-1b, IL-17 and IL-10 upon activation by various stimuli. [26] [27] [28] To assess if aBC affected cytokine production by these cells, bone-marrow-derived CD45 + CD11b + Ly6G + neutrophils (Fig. 1a) were stimulated with rm-GM-CSF + LPS with or without aBC addition. Although TNF-a and IL-6 production increased with stimulation, aBC did not alter the secretion of these cytokines from either stimulated or unstimulated neutrophils (Fig. 1b,c) . For other pro-inflammatory cytokines, such as IL-1b and IL-12p40, production of these signalling factors was not altered following stimulation or upon aBC treatment relative to media levels (Fig. 1d,e) . With respect to immunosuppressive cytokines, very low levels of IL-4 could be detected and remained unchanged among the various groups (Fig. 1f) . For IL-10, however, a significant increase was evident following GM-CSF + LPS stimulation, which was modestly, but consistently significantly enhanced when aBC was present (Fig. 1g) . are not always beneficial to the host if they are not controlled. For example, proteases and ROS released by neutrophils can cause significant tissue damage and pathology if not abated. 29 We therefore evaluated whether the secretion of ROS and two prominent MMPs in the neutrophil repertoire (neutrophil collagenase, MMP8, gelatinase B, MMP9) were impacted by aBC. MMPs play an important role in neutrophil migration and tissue damage in diseases such as RA. 30, 31 As well, both immune-suppressing and immune-activating functions of MMP8 have been reported. Both MMP8 and MMP9 secretion were enhanced when neutrophils were stimulated with rm-GM-CSF + LPS (Fig. 2) . However, while MMP9 levels remained unchanged in the presence of the heat-shock protein (Fig. 2a) , MMP8 production displayed a small significant increase upon application of aBC to stimulated cells (Fig. 2b) . We then proceeded to assess if the crystallin impacted the secretion of H 2 O 2 , an indicator of the ROS effector program in neutrophils. Using an AmplexRed assay, we found that neutrophils stimulated with GM-CSF + LPS alone did not release measurable amounts of H 2 O 2 after stimulation (Fig. S1 ). The protocol was therefore modified whereby cells were first activated with GM-CSF + LPS with and without aBC, and then activated with serum-opsinized zymosan. Neutrophils primed for 2 hr displayed no increase in H 2 O 2 secretion (Fig. 3a) . However, an enhancement was evident at 4 hr (Fig. 3a) . At this time point, a small but significant decrease in H 2 O 2 synthesis towards control levels was observed in the presence of aBC (Fig. 3b) . Intriguingly, but not unprecedented, 32 a reduction in ROS production was seen at 20 hr poststimulation relative to media controls (Fig. 3c) . Here again, a small but significant increase in H 2 O 2 levels again towards control levels was seen when aBC was applied to cells (Fig. 3c) .
aBC did not affect the expression of CD11b or iNOS
Upon activation, neutrophils usually upregulate iNOS production and membrane expression of CD11b. [33] [34] [35] During the degranulation process, granules containing CD11b in their membranes fuse with the cell membrane to increase the presence of this protein on the cell surface. Neutrophils then use this CD11b for migration into tissue and to communicate directly with other immune cells, such as DCs and T-cells. 9, 36 We therefore assessed whether CD11b expression was altered by aBC at 20 hr post-GM-CSF + LPS stimulation. Although stimulated neutrophils showed an increase in CD11b mean fluorescence index as compared with media control, aBC treatment did not alter cell surface expression of CD11b in stimulated cells (Fig. S2a) . We then considered the effect of aBC treatment on iNOS synthesis following GM-CSF + LPS stimulation in the presence or absence of aBC. Neutrophils stimulated for 2 or 6 hr but not 20 hr displayed increased levels of iNOS mRNA as compared with (Fig. S2b) . Treatment of activated cells with aBC did not, however, alter the level of iNOS mRNA at any of the time points (Fig. S2b) .
DCs co-cultured with aBC-treated neutrophils produce less IL-12p40
Because neutrophils are known to communicate with DCs to modulate the activation of both DCs and lymphocytes, 8, 10 and that aBC was found to have a small effect on some of the effector properties of neutrophils (augmentation of IL-10 and MMP8 secretion, altered H 2 O 2 release), we evaluated if aBC-treated neutrophils could change the activation of DCs. Neutrophils were stimulated with GM-CSF + LPS with and without aBC, and seeded on top of CD45 + CD11c + DCs (Fig. 4a ) in a 1 : 5, 1 : 2Á5 and 1 : 1 ratio. We then measured for the levels of IL-1b and IL-12p40, which are produced by DCs, but not our neutrophils grown in isolation (Fig. 1d,e) . DCs cocultured with GM-CSF + LPS-stimulated neutrophils produced significant amounts of IL-1b and IL-12p40 ( Fig. 4b-g ). Following aBC treatment of GM-CSF + LPSstimulated neutrophils, secretion of IL-1b by DCs remained unchanged relative to stimulation alone ( Fig. 4b-d) . For IL-12p40, however, a reduction was evident in the group whose neutrophils had been previously treated with the crystallin as compared with those DCs cultured with untreated stimulated neutrophils (Fig. 4e-g ). Moreover, the reduction in IL-12p40 by DCs occurred in a cell ratio-dependent manner. Specifically, DCs cultured in a 1 : 5 ratio with aBC-treated neutrophils displayed the largest reduction in IL-12p40 secretion (Fig. 4e) , followed by the cells grown in a 1 : 2.5 ratio (Fig. 4f) . Cells cultured at a 1 : 1 density did not have a significant reduction in IL-12p40 secretion (Fig. 4g) . It is also important to note that DCs that were grown with the washed supernatant from neutrophil-free wells containing only stimulation reagents did not exhibit any secretion of IL-1b and IL-12p40 (Fig. S3) , indicating that the changes in IL-1b and IL-12p40 were specifically related to the neutrophils and not to stimulation contamination. In addition, aBC treatment did not affect the viability of these cells as assessed by propidium iodide and Annexin V staining (Fig. S4a,b) , suggesting that in this case the viability of the neutrophils did not influence the communication between neutrophils and DCs. This effect of aBC-treated neutrophils on DCs appears to be specific to pro-inflammatory cytokine production, particularly IL12p40, and not the antigen-presenting machinery or interactive ability between the two cell types because the expression of antigen-presenting molecules (CD40, CD80, CD86, MHC II) on DCs (Fig. S5a-d) and number of contacts (Fig. S5e,f) between DCs and neutrophils were unchanged by the presence of the heat-shock protein. The latter observation is likely related to the finding that the secretion of two chemokines that are produced by neutrophils and known to attract DCs to allow for direct cell-to-cell engagement, MIP-1a (CCL3) and MCP-1 (CCL2), 14, 28, [37] [38] [39] was also not altered by aBC in unactivated or stimulated neutrophils (Fig. S5g,h ).
aBC pre-treated neutrophils reduce IL-12p40 secretion by DCs in a non-contact-dependent manner Thus far, we discovered that prior aBC-treated neutrophils were capable of reducing pro-inflammatory cytokine (IL-12p40) production by DCs when co-cultured together. Neutrophils can indeed alter the response of other immune cells through direct cell-to-cell contact, which could be the case in our situation. However, because no observed difference was seen in the interactions between neutrophils and DCs, we assessed whether aBC-treated neutrophils could also impact DC function in a non-contact-dependent manner, that is, via secretory factors. To test this idea, a transwell system was implemented. Similar to that seen in the contact-dependent assay (Fig. 4) , IL-1b secretion by DCs was not altered when co-cultured with stimulated and aBC-treated neutrophils in the transwell scenario (Fig. 5a ). For IL-12p40, however, DCs secreted significantly less of this cytokine when grown with aBC-treated stimulated neutrophils as compared with untreated neutrophils (Fig. 5b) . Our data therefore suggest that aBC treatment of neutrophils results in repressed IL-12p40 production by DCs via a secreted factor(s).
aBC-mediated increase in IL-10 production may involve PI3K and MEK/ERK Finally, in an effort to decipher the molecular mechanism (s) underlying the small effect of aBC on IL-10, MMP and ROS production by neutrophils, we evaluated the importance of the MAPK and PI3K pathways as they are known to be involved in the secretion of IL-10 and degranulation by neutrophils. 40, 41 Also, aBC treatment has been shown to affect various MAPK pathways as well as PI3K. 42, 43 We therefore investigated if these signalling pathways were involved in the enhanced secretion of IL-10 using inhibitors against p38 (SB203580), PI3K (LY294002), MEK/ERK (U0126) and JNK (JNKII). 40 Inhibition of the JNK pathway did not alter the secretion of IL-10 by either unstimulated or activated neutrophils (Fig. 6a) , whereas SB203580 reduced the production of IL-10 in both non-aBC-stimulated and aBC-treated neutrophils (Fig. 6b) . Of interest, PI3K and MEK/ERK inhibition resulted in a reduction of IL-10 in stimulated neutrophils, but the decrease was only significant in cells that had been incubated with aBC (Fig. 6c,d ). To ensure that the PI3K and MEK/ERK-induced reduction in IL-10 secretion was not due to cell death, the viability of the cells was evaluated by propidium iodide staining for nonviable cells. None of the kinase inhibitors altered the viability of non-stimulated, GM-CSF + LPS-stimulated or aBC-treated cells (Fig. S4c) , suggesting that the reduction in IL-10 production with the inhibitors was not related to cell death.
Discussion
Neutrophils are imperative for protecting the host against invading microbes. Unfortunately, over-exuberant activation of these granulocytes in autoimmune diseases, sterile injury and infection can result in direct damage to host tissue and/or prolongation of the inflammatory reaction due to interactions between neutrophils and other immune cells. It is thus important to understand if suppressors of neutrophil activation could be identified so as to reduce aberrant neutrophil responses. Neutrophils can dampen inflammation by acting directly on T lymphocytes and APCs, or through their own engulfment by APCs such as DCs. [44] [45] [46] Because aBC has been shown to suppress the activation and function of T-cells and macrophages, we investigated if the small heat-shock protein could also reduce neutrophil activation. We found that the heat-shock protein had a small but significant effect on selective properties of neutrophils, specifically IL-10, MMP8 and H 2 O 2 secretion, and that aBC-treated neutrophils were capable of suppressing pro-inflammatory cytokine production, specifically IL12p40, by DCs. Neutrophils, IL-10 and MMP8
IL-10 production is upregulated during the height of inflammatory reactions where it contributes to refraction of the reaction. 47 For example, IL-10 plays a role in suppressing Th1 CD4 + T-cell and CD8 + T-cell responses by downregulating MHC II and co-stimulatory molecule expression on APCs, thereby reducing antigen presentation by APCs and thus T-cell activation. 48 With respect to MMP8, this metalloproteinase has been reported to possess both pro-and antiinflammatory functions [49] [50] [51] in addition to its expected proteinase activity -it is involved in the breakdown of type I, II and III collagens. 52 Further, MMP8 secretion is differentially altered depending on the activator. 53 We speculate that the small effect of aBC in augmenting the secretion of IL-10 and MMP8 in neutrophils is by mediating the release of certain granules within neutrophils that contain these factors. Neutrophils contain granules that are formed sequentially during development in the bone marrow and contain particular molecules based on what is being synthesized at the time of formation. 54 Secondary (or specific) granules contain MMP8, and are speculated to be formed during myelocyte and metamyelocyte phases of neutrophil maturation. The IL-10 receptor is also known to reside within secondary granules 55 and, although not well characterized, IL-10 secretion may also be associated with release of these granules. 56 Further, IL-10 transcription can be regulated by C/EBPa, which is the dominant transcription factor active during secondary granule formation. 54, 57 It is possible that aBC treatment is enhancing the release of secondary granules to result in the dual secretion of IL-10 and MMP8. A feedback loop may also be involved whereby MMP8 mediates IL-10 production as MMP8 is thought to have a role in processing IL-10. 58 
Neutrophils and PI3K/MAPK signalling
The PI3K and MAPK pathways have a demonstrated involvement in not only primary and secondary granule release 59, 60 by neutrophils, but also the secretion of IL-10 by these cells. 40 For instance, the release of lactoferrin, one of the defining molecules present within secondary granules, is regulated by PI3K, p38 and ERK 61 in response to the complement protein, c5a. We found that the small aBC-augmented IL-10 secretion was significantly reduced by PI3K and MEK/ERK inhibitors, while others have shown that MMP8 production is augmented by c-MET through the PI3K and MEK/ERK pathways. 62 Because the crystallin has been found to act through the PI3K, MEK/ ERK and p38 signalling in relation to its anti-apoptotic and immunosuppressive functions, 63, 64 it is possible that aBC is acting through these kinase pathways to enhance the release of secondary granules and/or IL-10 and MMP8 production directly.
Neutrophils, ROS and aBC
We observed that neutrophils that were primed with GM-CSF + LPS for short periods of time and further stimulated with zymosan showed a small increase in H 2 O 2 secretion, whereas those cells primed for longer periods displayed decreased H 2 O 2 secretion. This divergence in H 2 O 2 (indicative of ROS) production over time has been observed by others. Saturnino et al. 32 found that mast cells also experience this effect when primed for long periods with endotoxin. Further, 'immunosuppressive' neutrophils have been associated with both low and high levels of ROS generation that was related to the length of stimulation of the cells. 65 Regarding aBC and ROS, the crystallin has been shown to inhibit the generation of ROS in response to Cu 2+ stimulation of lens epithelial cells. 66 In this situation, aBC sequestered the Cu 2+ to reduce the reason for ROS production, but this is unlikely in our case as aBC was removed before stimulating these cells with zymosan. Also, because treatment of neutrophils with the heat-shock protein during priming appeared to return H 2 O 2 production by neutrophils to an unprimed level of secretion, it suggested that aBC could affect the priming of these cells. However, because the effects of aBC on IL-10, H 2 O 2 and MMP8 are small, the crystallin is likely not a major modulator of neutrophil priming and effector abilities.
Neutrophils and IL-12p40 production in DCs
Stimulated neutrophils are known to upregulate the production of IL-12p40 and TNF-a by DCs. 67 DCs utilize IL12p40 to mediate differentiation of na€ ıve T lymphocytes into a Th1 68 or Th17 69,70 phenotype. IL-10 opposes this process, and the ratio of IL-12 : IL-10 is often used to assess inflammatory status. 71, 72 Interestingly, even though the effects of aBC on IL-10, H 2 O 2 and MMP8 were small, treatment of neutrophils with the crystallin was capable of reducing secretion of IL-12p40 by co-cultured DCs in a cell-ratio-dependent manner. It is possible then that aBC-treated neutrophils could contribute to reducing the overall pro-inflammatory milieu by suppressing DC proinflammatory state, while at the same time suppressing the ability of DCs to polarize T-cells towards a Th1 or Th17 phenotype and thus tipping the inflammatory reaction towards a dampening phenotype.
An interesting observation was the ability of aBC-treated neutrophils to suppress IL-12p40 secretion by DCs in both a contact-dependent and non-dependent manner. Because the interactions between neutrophils and DCs were not altered in the presence of aBC, the transwell experiment suggests that stimulated neutrophils treated with aBC secreted less of an unknown factor(s) that normally drives the secretion of IL-12p40 by DCs. One mechanism that neutrophils employ to induce IL-12p40 secretion by DCs is through secretion of TNF-a. 14 We do not think that TNF-a is the unknown secretory factor because production of the cytokine was not changed in aBC-treated neutrophils (Fig. 1b) . An alternate possibility is that aBC-treated neutrophils secreted a molecule(s) that suppressed the production of IL-12p40 by DCs. Many factors are known to regulate the expression of IL-12p40 by DCs including IL-10. 73 Since we found that IL-10 was elevated in aBC-treated neutrophils, it is conceivable that the immunosuppressive cytokine could contribute to suppressing DC IL-12p40 production. Another possibility is that neutrophil elastase (NE), which was found to be inhibited by aBC, 74 may contribute to the reduced secretion of IL-12p40 by DCs. NE has been shown to reduce IL-12 production by macrophages, 75 and it is possible that a similar process may occur in mature DCs.
In summary, treatment of neutrophils with aBC peptide led to small increases in IL-10 and MMP8 secretion as well as suppressed secretion of the pro-inflammatory cytokine, IL-12p40, by DCs. These data suggest that the small heat-shock protein is likely not a major player in neutrophil priming and effector abilities, but its limited effects on neutrophil physiology may contribute to impacting overall inflammatory responses via dampening of DC IL-12p40 production. 
Supporting Information
Additional Supporting Information may be found in the online version of this article: Figure S1 . Hydrogen peroxide secreted by neutrophils stimulated with GM-CSF + LPS and treated with aBC for two (black bars), four (dark grey bars), or 20 hr (light grey bars) with no further stimulation. Combined data from 3 individual experiments. Error bars represent spread of data from minimum to maximum. Statistical analyses were completed by repeated measures two-way ANOVA with S ıd ak post hoc test. 
